Galderma, CH1335392721

Galderma stock: Shareholders approve CHF 0.35 dividend

Published on 11/09/2026 at 11:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Galderma stock remains tied to a shareholder-approved payout and refreshed board composition. The April meeting also backed the company's 2025 reporting.

Shareholders backed dividend and board

  • The April meeting approved the board's proposals and a shareholder distribution from capital contribution reserves.
  • Harry Kirsch joined the board as an independent director, while two L'Oreal representatives were elected as non-independent members.
  • Galderma's 2025 financial, non-financial and compensation reports also received shareholder approval.
Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma shareholders approved all proposals put forward by the board at the company's Annual General Meeting in Zug on April 22, 2026. The company described the outcome in its AGM release.

Dividend and board changes

The meeting approved a gross dividend of CHF 0.35 per dividend-bearing share. The distribution is to be made from reserves from capital contributions, subject to the conditions described by Galderma under Swiss tax rules.

Harry Kirsch was elected as an independent board member. Samuel du Retail and Delphine Viguier-Hovasse, both representatives of L'Oreal, were elected as non-independent members. Thomas Ebeling, Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Flemming Ornskov were re-elected.

The resolutions preserve broad continuity on the board while adding two L'Oreal-linked directors and an independent member. For investors, the AGM therefore combined a shareholder distribution with a change in board representation.

Reporting approvals add continuity

Shareholders also approved Galderma's 2025 Annual Financial Statements, Non-Financial Report and Compensation Report. The company said detailed voting results and the official minutes would be published on its investor-relations website within two weeks of the meeting.

Galderma stock traded at 209.00 euros on Lang & Schwarz at 11:46 CET on Monday, November 9, 2026. Investors can follow the real-time quote of Galderma stock.

Galderma at a glance

  • Company: Galderma Group AG
  • ISIN: CH1335392721
  • Quote: 209.00 euros on Lang & Schwarz at 11:46 CET on November 9, 2026
  • AGM: April 22, 2026, in Zug
  • Approved dividend: CHF 0.35 gross per dividend-bearing share

The SMI market environment provides the broader Swiss equity backdrop for investors.

For more company-specific developments, see more news and analyses on Galderma stock.

Disclaimer...
en | CH1335392721 | GALDERMA | boerse | 70480367 |